Dr Paul Mulholland, Consultant Medical Oncologist
Dr Paul Mulholland
Consultant Medical Oncologist
Dr Paul Mulholland MBBS, MSc, PhD, MRCP
Consultant Medical Oncologist
Dr Paul Mulholland
Consultant Medical Oncologist MBBS, MSc, PhD, MRCP
Dr Mulholland is a Consultant Medical Oncologist
Areas of expertise
- Brain cancer
- Central nervous system cancer
- Novel agents including immunotherapy and vaccine therapy
Make an appointment
Address
-
HCA UK at University College Hospital
Grafton Way Building, 1 Grafton Way, London, WC1E 6AG
About Dr Paul Mulholland
GMC number: 3690279
Year qualified: 1992
Place of primary qualification: University of London
Dr Paul J. Mulholland is a distinguished medical oncologist specialising in brain cancer. He practices at University College Hospital, the National Hospital for Neurology and Neurosurgery (part of UCLH). Dr Mulholland has been serving in these esteemed institutions since his appointment in 2005.
He is also an honorary associate professor at University College London (UCL) and a training programme director. His doctoral research focused on genomic profiling in brain cancer at Cancer Research UK, which has driven his dedication to developing biomarkers and therapeutic targets for brain cancer. Dr Mulholland manages a clinical trial portfolio of novel agents in brain cancer at UCLH and on a national level.
In recent years, his focus has moved towards including immunotherapy in the treatment of brain cancer.
Areas of expertise
- Brain cancer
- Central nervous system cancer
- Novel agents including immunotherapy and vaccine therapy
Professional memberships
Articles by Dr Paul Mulholland
A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma
CITADEL-123: A Phase I clinical trial to assess the activity of I-123 Poly Adenosine Diphosphate Ribose Polymerase I inhibitor (123I-ATT001) directly administered in subjects with relapsed glioblastoma
